Testosterone, The New Craze, Not Without Risks

Testosterone is all over the T.V screen. You see testosterone  clinics promoting it for youth, virility and muscle mass and lawyer ads for the dangers and risks. It appears this new found fountain of youth is being investigated by the FDA for heart attacks and strokes in men over the age of 65. That is our huge baby boomer population. The 65 of today is not your parents or grandparents. They are active males who exercise and are out beating the social track. They are found in places like California and Florida where the warm weather makes for a desire to look good.

Testosterone is offered in: patches, gels, buccal gum  patch, injections and  subcutaneous pellets placed under your skin.

The huge market for testosterone concerns doctors.

 “Have you noticed a recent deterioration of your ability to play sports?” “Do you have a decrease in sex drive?” “Do you have a lack of energy?” The manufacturers are enticing the older male, but, the warnings are not there.

Axiron, a testosterone gel by Eli Lilly & Company, sells for more than $500 a month retail, and about $400 with pharmacy

Sales of prescription testosterone gels that are absorbed through the skin generated over $2 billion in American sales last year.

Lawyer Ads For Heart Attacks and Stroke From Testosterone

We are now seeing lawyer ads for victims of heart attacks and strokes from Low T Therapy. The FDA is now inveatigating this link between testosterone off label use and cardiac injury.

Testosterone was only approved  by the FDA for medical conditions.

FDA Warning For Testosteone Below

Testosterone Products: Drug Safety Communication – FDA Investigating Risk of Cardiovascular Events

[Posted 01/31/2014]

AUDIENCE: Cardiology, Urology, Family Practice

ISSUE: FDA is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products. We have been monitoring this risk and decided to reassess this safety issue based on the recent publication of two separate studies that each suggested an increased risk of cardiovascular events among groups of men prescribed testosterone therapy. FDA is providing this alert while it continues to evaluate the information from these studies and other available data. FDA will communicate final conclusions and recommendations when the evaluation is complete.

Speak to a lawyer if you were injured by testosterone by calling 1 877 522-2123